EFTA01582315.pdf

Statement of Account 21 **• ALL AMOUNTS IN US DOLLAR PORTFOLIO TYPE LONG OR DESCRIPTION PRICE MARKET ESTIMATED CURRENT SHORT IS) VALUE ANNUAL INCOME YIELD % EQUITIES 03 38,174 (S) ALLERGAN INC 107.96000 4,121,265.04- 15,269.60- .371 •CSFB RATING :NEUTRAL INDEPENDENT RATING:3 STAR - Hold PROVIDER:Standard 4 Poor's 03 17,250 (S) AMERICAN FINL GROUP INC 38.31000 660,847.50- 8,625.00- 1.305 •CSFB RATING :OUTPERFORM INDEPENDENT RATING: PROVIDER:Standard & Poor's 03 9,955 (S) AMGEN 78.86000 7e5,051.30- •CSFB RATING :NEUTRAL INDEPENDENT RATING:5 STAR - Buy PROVIDER:Standard & Poor's 03 22,400 (S) AMYLIN PHARMACEUTICALS INC 39.92000 894,208.00- 03 253 (S) BARNES GROUP INC 33.00000 8,349.00- 222.64- 2.667 03 12,523 (S) CBRL GROUP INC 35.15000 440,183.45- 6,511.96- 1.479 •CSFB RATING :NOT RATED INDEPENDENT RATING:2 STAR - Avoid PROVIDER:Standard fi PoOr'S 03 58,167 (S) CMS ENERGY CORP 14.51000 844,003.17- 03 11,164 (S) CSX CORPORATION 50.77000 566,796.28- 5,805.28- 1.024 •CSFB RATING :Neutral INDEPENDENT RATING:3 STAR - Hold PROVIDER:Standard & Poor's 03 426 (S) CV THERAPEUTICS INC 24.73000 10,534.98- 03 25,500 (S) CELGENE CORPORATION 64.80000 1,652,400.00- 03 149,200 (S) CENTERPOINT ENERGY INC 12.85000 1,917,220.00- 35,808.00- 1.868 •CSFB RATING :NEUTRAL INDEPENDENT RATING:3 STAR - Hold PROVIDER:Standard & Poor's 01 10,000 CENTERPOINT ENERGY INC 12.85000 128,500.00 2,400.00 1.868 •CSFB RATING :NEUTRAL INDEPENDENT RATING:3 STAR - Hold PROVIDER:Standard & Poor's CREDIT FIRST SUISSE I BOSTON Confidential Treatment Requested by JPMorgan Chase JPM-SDNY-00061838 EFTA01582315